RewordedRisk Factors
There were no As of December 31, 2025, outstanding borrowings on the Revolving Facility, which has an expiration date of Facility were $107.0 million, bearing interest at 6.39% and maturing May 2029, however and we had unused letters of credit issued under the Revolving Facility of $12.0 $16.0 million.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
Our business may be harmed if we lose our relationships with insurance and reinsurance company partners, referral partners or other trading partners, fail to maintain good relationships with insurance and reinsurance company partners, referral partners or other trading partners, become dependent upon a limited number of insurance and reinsurance company partners, referral partners or other trading partners or fail to develop new insurance and reinsurance company partner, referral partner or other trading partner relationships.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
As of December 31, 2024, 2025, we had $1.5 billion of goodwill recorded on our balance sheet, which represented 40% 39% of our total assets.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
Goodwill is not amortized and is subject to assessment for impairment when the facts and circumstances suggest an impairment test is necessary, but in any event, at least annually.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
Following the successful refinancing of our Term Loan B on January 10, 2025, 2, 2026, borrowings under our 2024 JPM Credit Agreement include $935.8 million $1.604 billion under the Term Loan B bearing interest of 7.30%, 6.25%, maturing May 2031.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
On May 24, 2024, As of December 31, 2025, we issued had $600.0 million in aggregate principal amount of the 7.125% Senior Secured Notes due May 2031.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
Unfavorable ratings of Baldwin or our industry, as well as omission of inclusion of our stock into ESG-oriented investment funds may lead to negative investor sentiment and the diversion of investment to other companies or industries, which could have a negative impact on the price of our stock price. Class A common stock.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
We may issue a substantial amount of our common stock in the future, which could cause dilution to investors and otherwise adversely affect the price of our stock price. Class A common stock.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
As of December 31, 2024, 2025, our cash and cash equivalents were $148.1 $123.7 million and we had $588.0 $477.0 million of available borrowing capacity on the Revolving Facility under the 2024 JPM Credit Agreement.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
Based on estimates of the partners’ future performance using financial projections for the earnout period, the aggregate estimated contingent earnout liabilities included on our consolidated balance sheet at December 31, 2024 2025 was $145.6 $23.3 million, of which $4.7 $9.2 million must be settled in cash and the remaining $140.8 $14.1 million can be settled in cash or stock at our option.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedRisk Factors
The undiscounted estimated contingent earnout obligation at December 31, 2024 2025 was $185.2 $26.6 million, of which $5.0 $9.2 million must be settled in cash and the remaining $180.2 $17.4 million can be settled in cash or stock at our option.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
Effective January 1, 2026, the Company acquired the outstanding equity interests of the business of CAC Group for aggregate consideration paid by the Company at closing consisting of $438.0 million of cash (subject to customary purchase price adjustments) and 23,200,000 shares of the Company's Class A common stock. The purchase consideration also includes a deferred payment of $70.0 million in cash, payable upon the fourth anniversary of the closing date of the CAC Group Transaction. CAC Group may be entitled to receive up to $250.0 million of additional contingent consideration payable in cash based upon the achievement of certain post-closing revenue focused performance measures. The partnership with CAC Group will significantly expand the specialty capabilities of the Company's IAS operating group and strengthen its specialty product lines and data and analytics platform.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
Colleague compensation and benefits expense increased $15.3 million, or 2%, year over year. Partnership activity contributed $8.2 million to the increase in colleague compensation and benefits in 2025, offset in part by a $1.4 million decrease related to our Wholesale Business, which was sold in the first quarter of 2024. After excluding colleague compensation and benefits expense related to our partnerships and divestitures, colleague compensation and benefits expense increased $8.5 million due to increases in colleague compensation of $33.8 million, inside advisor commissions of $8.9 million and benefits and other of $8.4 million as a result of the continued investment in our growth and elevated health plan costs, offset in part by a decrease in colleague earnout incentives of $43.7 million resulting from settlement activity in 2025.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
Right-of-use assets and operating lease liabilities decreased $10.4 million and $10.1 million, respectively, due to ongoing measures to consolidate our facilities footprint in certain geographies.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
Commissions payable decreased $22.2 million driven primarily by the timing of commission payments relative to the timing of collections from clients.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
Accrued expenses and other current liabilities increased $86.7 million as a result of increases in accrued expenses relating, in part, to the timing of expenses incurred in connection with January 2026 partnerships, deferred payments relating to 2025 partnerships, and accrued compensation and benefits relating to our overall growth and increased health insurance costs.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
Colleague earnout incentives decreased $32.8 million as a result of settlement activity in 2025.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
The revolving line of credit increased $107.0 million driven by draws to support growth in our business, including the 2025 partnerships.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
Long-term debt increased $172.2 million due to the 2025 Refinancings during which we upsized the Term Loans by $175.0 million in the aggregate to support growth in our business, including our 2025 partnerships.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
Fiduciary assets and liabilities increased $78.5 million and $79.0 million, respectively, attributable to overall growth in our business and higher volumes of agency bill premium activity, as well as the timing of cash collections and carrier payable settlements.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
(1) Transformation costs represent certain non-recurring colleague compensation and technology-related expenses related to our $3B/30 Catalyst Program, which is designed to accelerate the infusion of automation, business process optimization and artificial intelligence to transform and elevate our workforce and unlock new avenues for growth.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
(1) Transformation costs represent certain non-recurring colleague compensation and technology-related expenses related to our $3B/30 Catalyst Program, which is designed to accelerate the infusion of automation, business process optimization and artificial intelligence to transform and elevate our workforce and unlock new avenues for growth.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
AddedMD&A
Colleague compensation and benefits expense for UCTS increased $15.0 million, or 15%, year over year. Partnership activity contributed $6.4 million to the increase in colleague compensation and benefits in 2025, offset in part by a $1.4 million decrease related to the divestiture of our Wholesale Business during 2024. After excluding colleague compensation and benefits expense related to partnership and divestiture activity, colleague compensation and benefits increased $10.0 million, or 10%, as a result of the continued investment in UCTS' growth and elevated health plan costs.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RemovedMD&A
Investment income is earned by investing assets held in trust. Investment income increased $5.2 million year over year due to improvements in our cash management strategy and growing yield on our invested cash.
Read it in 10-K Feb 25, 2025 at sec.govopen_in_new
RemovedMD&A
Commissions, employee compensation and benefits expense increased $120.7 million, or 13%, year over year, primarily related to outside commissions, which increased $74.1 million, after excluding outside commissions related to the Wholesale Business between March and December of 2023 of $15.8 million, due to growth in UCTS and MIS. In addition, colleague earnout incentives, which relate to contingent earnout liabilities that were reclassified, at the partner's option, to an earnout incentive bonus payable to colleagues, increased $33.4 million. Other increases, after excluding amounts related to the Wholesale Business between March and December of 2023, were driven by continued investments in headcount to support the growth of existing and new products, including colleague compensation (fixed compensation plus share-based compensation) of $21.5 million, inside advisor commissions of $15.5 million, and benefits and other expense of $12.3 million. These increases were partially offset by commissions, employee compensation and benefits expense of $23.7 million incurred by our Wholesale Business between March and December of 2023, for which there were no comparable costs incurred in 2024, and a decrease in severance expense of $12.6 million relating primarily to the retirement of two of our executive officers at the end of 2023.
Read it in 10-K Feb 25, 2025 at sec.govopen_in_new
RemovedMD&A
Long term debt increased $428.0 million and our revolving line of credit decreased $341.0 million due to the May 2024 refinancing in which we upsized the term loan under a new $840 million senior secured first lien term loan facility and entered into a new senior secured first lien revolving facility with commitments in an aggregate principal amount of $600 million. Proceeds from the May 2024 refinancing were used to paydown our revolving line of credit.
Read it in 10-K Feb 25, 2025 at sec.govopen_in_new
RemovedMD&A
Effective January 1, 2024, our FounderShield Partner moved from UCTS to IAS. Prior year results of operations for IAS below have been recast to conform to the current organizational structure.
Read it in 10-K Feb 25, 2025 at sec.govopen_in_new
RemovedMD&A
IAS investment income increased $2.0 million year over year due to improvements in our cash management strategy and growing yield on our invested cash.
Read it in 10-K Feb 25, 2025 at sec.govopen_in_new
RemovedMD&A
Effective January 1, 2024, our FounderShield Partner moved from UCTS to IAS. Prior year results of operations for UCTS below have been recast to conform to the current organizational structure.
Read it in 10-K Feb 25, 2025 at sec.govopen_in_new
RemovedMD&A
Profit-sharing and other revenue decreased $12.2 million year over year, of which, $7.5 million is a function of strong profit-sharing revenue in 2023, which resulted from historically strong underwriting performance in that year. The remaining decrease relates to profit-sharing and other income earned by our Wholesale Business between March and December of 2023, for which there were no comparable revenues earned in 2024, and a reduction in other income.
Read it in 10-K Feb 25, 2025 at sec.govopen_in_new
RemovedMD&A
UCTS investment income increased $2.0 million year over year due to improvements in our cash management strategy and growing yield on our invested cash.
Read it in 10-K Feb 25, 2025 at sec.govopen_in_new
RemovedMD&A
Commissions, employee compensation and benefits expense for UCTS includes both outside commissions paid to partners that distribute our MGA products and compensation paid primarily to colleagues. Commissions, employee compensation and benefits expense for UCTS increased $63.6 million year over year, primarily driven by outside commissions, which increased $66.8 million, or 35%, in line with the growth in UCTS core commissions and fees after excluding outside commissions relating to the Wholesale Business between March and December of 2023 of $15.8 million. Other increases, after excluding amounts relating to the Wholesale Business between March and December of 2023, included benefits and other expense of $7.0 million and colleague compensation of $8.9 million, which were driven by continued investments in headcount to support the growth of existing and new products, coupled with an increase in colleague compensation allocated to UCTS that was previously recognized in Corporate and Other. These increases were partially offset by compensation costs of $23.7 million incurred by our Wholesale Business between March and December of 2023, for which there were no comparable costs incurred in 2024.
Read it in 10-K Feb 25, 2025 at sec.govopen_in_new
RemovedMD&A
A substantial portion of the intercompany commissions revenue recorded during 2024 is related to the QBE Program Administrator Agreement. We expect intercompany commissions revenue to continue to grow as we serve as the MGA on more intersegment revenue such as homeowners insurance sold through MIS.
Read it in 10-K Feb 25, 2025 at sec.govopen_in_new
RemovedMD&A
Commissions, employee compensation and benefits expense in Corporate and Other decreased $58.0 million year over year, driven by a reduction in colleague compensation of $31.5 million, due in part to a decrease in corporate-related headcount, including the retirement of two of our executive officers at the end of 2023, coupled with a decrease in colleague compensation previously recognized in Corporate and Other that is now allocated to the operating groups. Other decreases included severance of $11.9 million relating to the retirement of two of our executive officers at the end of 2023 as mentioned above, and $11.5 million relating to an increase in intercompany commissions expense eliminations.
Read it in 10-K Feb 25, 2025 at sec.govopen_in_new
RemovedMD&A
A significant portion of the year-over-year increase in intercompany commissions expense eliminated through Corporate and Other is related to the QBE Program Administrator Agreement. We expect intercompany commissions expense to continue to increase as we serve as the MGA on more intersegment revenue such as homeowners insurance sold through MIS.
Read it in 10-K Feb 25, 2025 at sec.govopen_in_new
RewordedMD&A
For the Years Ended December 31, (in thousands, except per share data) 2025 2024 2023 Net loss attributable to Baldwin $ (33,813) $ (24,518) $ (90,141) Net loss attributable to noncontrolling interests (20,341) (16,563) (73,878) Amortization expense 121,316 102,730 92,704 Share-based compensation 71,113 65,503 56,222 Colleague earnout incentives 41,917 8,020 Gain on divestitures (38,953) Transaction-related partnership and integration expenses 23,051 10,501 Transformation costs(1) 7,003 — Severance 6,790 5,756 Depreciation 6,514 6,194 Loss on extinguishment and modification of debt 6,226 15,113 — Transaction-related partnership and integration expenses 10,501 20,728 Depreciation 6,194 5,698 Income tax expense 6,537 — Amortization of deferred financing costs 5,841 5,129 Severance 5,756 18,514 Change in fair value of contingent consideration 5,594 (4,949) 61,083 Other amortization/accretion, net 4,190 5,841 Income tax expense(2) 2,172 6,537 Colleague earnout incentives (1,779) 41,917 Impairment of right-of-use assets 1,275 — Gain on divestitures (290) (38,953) Loss on interest rate caps, net of cash settlements 18 2,544 12,588 Other(1) Other(3) 21,762 18,682 28,834 Adjusted pre-tax income 220,801 196,335 145,501 Adjusted income taxes(2) taxes(4) 21,859 19,437 14,405 Adjusted net income $ 198,942 $ 176,898 $ 131,096 Weighted-average shares of Class A common stock outstanding - diluted 67,939 63,455 60,135 Dilutive weighted-average shares of Class A common stock 3,229 3,598 3,874 Exchange of Class B common stock(3) stock(5) 47,737 50,896 53,132 Adjusted diluted weighted-average shares outstanding 118,905 117,949 117,141 Diluted loss per share $ (0.50) $ (0.39) $ (1.50) Effect of exchange of Class B common stock and net loss attributable to noncontrolling interests per share 0.04 0.10 0.04 Other adjustments to loss per share 2.31 2.01 2.64 Adjusted income taxes per share (0.18) (0.16) (0.12) Adjusted diluted EPS $ 1.67 $ 1.50 $ 1.12
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
Interest expense, net 122,778 123,644 119,465 Amortization expense 121,316 102,730 92,704 Share-based compensation 71,113 65,503 56,222 Colleague earnout incentives 41,917 8,020 Gain on divestitures (38,953) Transaction-related partnership and integration expenses 23,051 10,501 Transformation costs(1) 7,003 — Severance 6,790 5,756 Depreciation expense 6,514 6,194 Loss on extinguishment and modification of debt 6,226 15,113 — Transaction-related partnership and integration expenses 10,501 20,728 Income and other taxes(1) 7,184 1,285 Depreciation expense 6,194 5,698 Severance 5,756 18,514 Change in fair value of contingent consideration 5,594 (4,949) 61,083 Income and other taxes(2) 4,255 7,184 Colleague earnout incentives (1,779) 41,917 Impairment of right-of-use assets 1,275 — Gain on divestitures (290) (38,953) Loss on interest rate caps 18 244 1,670 Other(2) Other(3) 21,762 18,682 28,834 Adjusted EBITDA $ 341,472 $ 312,485 $ 250,204 Net loss margin (4) % (3) % (13) % Adjusted EBITDA margin 22.7 % 22.5 % 20.5 %
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
Net cash provided by used in investing activities increased $35.2 $153.6 million year over year, driven by net an increase in cash consideration paid for partnership activity of $85.7 million, a decrease in cash proceeds from divestitures divestitures, net of $57.0 cash transferred of $55.1 million, relating primarily to the sale of our Wholesale Business during 2024, offset and an increase in part by a decrease investments in cash relating and loans to higher capital expenditures business ventures, net of $19.7 repayments of $14.3 million due related to software development projects for infrastructure to support our business. investment in the Reciprocal in 2025.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
Net cash used in provided by financing activities increased $3.4 $182.8 million year over year, year driven by an increase in net proceeds from borrowings on our credit facilities of $99.4 $196.6 million primarily resulting from the May 2024 debt refinancing, offset 2025 Refinancings and borrowings on the Revolving Facility to fund partnerships and the payment of our earnout obligations during 2025, and a decrease in part by decreases in cash from additional payments of contingent earnout consideration classified as financing activity of $70.7 million, higher borrowing costs of $13.0 million, and fewer cash settlements from interest rate caps of $8.6 $32.5 million.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
Growth Total growth in our core commissions and fees of $71.4 million was driven by continued outperformance in our multi-family business MSI (accounting for $35.7 $41.2 million of the increase in core commissions and fees), momentum in our homeowners product the introduction of the Captive (accounting for $36.8 million of the increase in core commissions and fees) and commercial umbrella product (accounting for $9.9 $22.6 million of the increase in core commissions and fees), and growing contribution from building momentum in our reinsurance brokerage business Capacity Solutions group (accounting for $13.9 million of the increase in core commissions and commercial property program. fees).
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
For the Years Variance Ended December 31, (in thousands) 2025 2024 2023 Net cash provided by (used in) operating activities $ 102,151 (29,418) $ 44,644 51,453 $ 57,507 (80,871) Net cash provided by (used in) investing activities (140,276) 13,299 (21,922) 35,221 (153,575) Net cash used in provided by financing activities (29,644) (26,230) (3,414) 203,822 21,054 182,768 Net increase (decrease) in cash and cash equivalents and restricted fiduciary cash 34,128 85,806 (3,508) 89,314 (51,678) Cash and cash equivalents and restricted fiduciary cash at beginning of year period 312,769 226,963 230,471 (3,508) 85,806 Cash and cash equivalents and restricted fiduciary cash at end of year period $ 346,897 $ 312,769 $ 226,963 $ 85,806 34,128
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
This growth was offset in part by a decrease in commissions and fees of $28.8 $5.8 million derived from related to the divestiture of our Wholesale Business between March and December of 2023, for which there were no comparable revenues earned in 2024 as a result of the sale of the business in the first quarter of 2024.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
This growth was offset in part by a decrease in commissions and fees of $28.8 $5.8 million derived from related to the divestiture of our Wholesale Business between March and December of 2023, for which there were no comparable revenues earned in 2024 as a result of the sale of the business in the first quarter of 2024.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
We expect interest expense to remain relatively flat grow in the near term on a year-over-year basis due to an anticipated increase in higher borrowings from our revolving credit facility under the JPM Credit Facility to fund partnership opportunities and the settlement of contingent earnout liabilities, deferred payment obligations, offset slightly by a lower expected average interest rate. rates.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
We expect interest expense to remain relatively flat grow in the near term on a year-over-year basis due to an anticipated increase in higher borrowings from our revolving credit facility under the JPM Credit Facility to fund partnership opportunities and the settlement of contingent earnout liabilities, deferred payment obligations, offset slightly by lower expected average interest rates.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
We expect interest expense to remain relatively flat grow in the near term on a year-over-year basis due to an anticipated increase in higher borrowings from our revolving credit facility under the JPM Credit Facility to fund partnership opportunities and the settlement of contingent earnout liabilities, deferred payment obligations, offset slightly by lower expected average interest rates.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new
RewordedMD&A
Total other income income, net for UCTS increased $33.2 IAS decreased $3.5 million year over year, driven by a $35.1 $3.8 million gain recorded on divestitures in connection with 2024 related to the sale of our Wholesale Business during the first quarter certain books of 2024. business.
Read it in 10-K Feb 26, 2026 at sec.govopen_in_new